Mark Coleman - 18 Nov 2021 Form 4 Insider Report for Axsome Therapeutics, Inc. (AXSM)

Role
Director
Signature
/s/ Mark Coleman
Issuer symbol
AXSM
Transactions as of
18 Nov 2021
Net transactions value
+$50,181
Form type
4
Filing time
22 Nov 2021, 06:30:39 UTC
Previous filing
08 Jun 2021
Next filing
08 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXSM Common Stock Purchase $14,344 +409 +0.1% $35.07 421,407 18 Nov 2021 See Footnote F1
transaction AXSM Common Stock Purchase $35,837 +1,021 +0.24% $35.10 422,428 18 Nov 2021 See Footnote F1
holding AXSM Common Stock 4,100 18 Nov 2021 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Such shares were purchased by an entity, of which the reporting person has voting and dispositive power, and therefore, the reporting person is deemed to be the indirect beneficial owner of such shares.
F2 Represents additional shares held directly by the reporting person prior to November 18, 2021.